Order Article Reprints

Zhang M, Zhu J, Zheng Y, Guo R, Wang S, Mignani S, Caminade A-M, Majoral J-P, Shi X. Doxorubicin-Conjugated PAMAM Dendrimers for pH-Responsive Drug Release and Folic Acid-Targeted Cancer Therapy. Pharmaceutics. 2018; 10(3):162. https://doi.org/10.3390/pharmaceutics10030162

Zhang, Mengen, Jingyi Zhu, Yun Zheng, Rui Guo, Shige Wang, Serge Mignani, Anne-Marie Caminade, Jean-Pierre Majoral, and Xiangyang Shi. 2018. "Doxorubicin-Conjugated PAMAM Dendrimers for pH-Responsive Drug Release and Folic Acid-Targeted Cancer Therapy" Pharmaceutics 10, no. 3: 162. https://doi.org/10.3390/pharmaceutics10030162

Zhang, M., Zhu, J., Zheng, Y., Guo, R., Wang, S., Mignani, S., Caminade, A.-M., Majoral, J.-P., & Shi, X. (2018). Doxorubicin-Conjugated PAMAM Dendrimers for pH-Responsive Drug Release and Folic Acid-Targeted Cancer Therapy. Pharmaceutics, 10(3), 162. https://doi.org/10.3390/pharmaceutics10030162